{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:17:33Z","timestamp":1791807453625,"version":"4.3.4"},"reference-count":59,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,7,23]]},"DOI":"10.3233\/jad-181030","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T12:51:58Z","timestamp":1561467118000},"page":"553-562","source":"Crossref","is-referenced-by-count":39,"title":["Cortisol, Amyloid-\u03b2, and Reserve Predicts Alzheimer\u2019s Disease Progression for Cognitively Normal Older Adults"],"prefix":"10.1177","volume":"70","author":[{"given":"Chinedu T.","family":"Udeh-Momoh","sequence":"first","affiliation":[{"name":"Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK"},{"name":"Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Su","sequence":"additional","affiliation":[{"name":"Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK"},{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shireen","family":"Sindi","sequence":"additional","affiliation":[{"name":"Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK"},{"name":"Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Center for Alzheimer Research, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Tzoulaki","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Perneczky","sequence":"additional","affiliation":[{"name":"Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK"},{"name":"Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany"},{"name":"German Center for Neurodegenerative Disorders (DZNE), Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefkos T.","family":"Middleton","sequence":"additional","affiliation":[{"name":"Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-181030_ref1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An English translation of Alzheimer\u2019s 1907 paper, \u201cUber eine eigenartige Erkankung der Hirnrinde\u201d","volume":"8","author":"Alzheimer","year":"1995","journal-title":"Clin Anat"},{"key":"10.3233\/JAD-181030_ref2","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","article-title":"Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils","volume":"293","author":"Gotz","year":"2001","journal-title":"Science"},{"key":"10.3233\/JAD-181030_ref3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: The trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-181030_ref4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(88)92855-3","article-title":"Abnormal cortisol response in Alzheimer\u2019s disease linked to hippocampal atrophy","volume":"2","author":"de Leon","year":"1988","journal-title":"Lancet"},{"key":"10.3233\/JAD-181030_ref5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2174\/15672050113109990137","article-title":"Hypercortisolemia and glucocorticoid receptor-signaling insufficiency in Alzheimer\u2019s disease initiation and development","volume":"10","author":"Notarianni","year":"2013","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-181030_ref6","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1523\/JNEUROSCI.2797-06.2006","article-title":"Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer\u2019s disease","volume":"26","author":"Green","year":"2006","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-181030_ref7","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.1523\/JNEUROSCI.0730-11.2011","article-title":"Stress acts cumulatively to precipitate Alzheimer\u2019s disease-like tau pathology and cognitive deficits","volume":"31","author":"Sotiropoulos","year":"2011","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-181030_ref8","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.neurobiolaging.2012.11.015","article-title":"Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer\u2019s disease rat model","volume":"34","author":"Brureau","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-181030_ref9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1210\/edrv-7-3-284","article-title":"The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis","volume":"7","author":"Sapolsky","year":"1986","journal-title":"Endocr Rev"},{"key":"10.3233\/JAD-181030_ref10","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/npp.2015.25","article-title":"Subchronic glucocorticoid receptor inhibition rescues early episodic memory and synaptic plasticity deficits in a mouse model of Alzheimer\u2019s disease","volume":"40","author":"Lante","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-181030_ref11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.biopsych.2012.12.003","article-title":"Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology","volume":"74","author":"Baglietto-Vargas","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-181030_ref12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biopsych.2005.06.017","article-title":"Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer\u2019s disease","volume":"59","author":"Elgh","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-181030_ref13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0006-3223(94)91214-9","article-title":"Cortisol suppression by dexamethasone in the healthy elderly: Effects of age, dexamethasone levels, and cognitive function","volume":"36","author":"O\u2019Brien","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-181030_ref14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.155.2.286","article-title":"Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer\u2019s disease: Lack of association between longitudinal and cross-sectional findings","volume":"155","author":"Swanwick","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-181030_ref15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.neurobiolaging.2007.07.007","article-title":"CSF cortisol in Alzheimer\u2019s disease and mild cognitive impairment","volume":"30","author":"Popp","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-181030_ref16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neurobiolaging.2014.10.031","article-title":"Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer\u2019s type","volume":"36","author":"Popp","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-181030_ref17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3233\/JAD-2010-100663","article-title":"HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer\u2019s disease","volume":"22","author":"Gil-Bea","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181030_ref18","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1176\/ajp.2006.163.12.2164","article-title":"Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia","volume":"163","author":"Csernansky","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-181030_ref19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.0000000000003537","article-title":"Long-term cortisol measures predict Alzheimer disease risk","volume":"88","author":"Ennis","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-181030_ref20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-2009-1152","article-title":"Effects of stress and stress hormones on amyloid-beta protein and plaque deposition","volume":"18","author":"Dong","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181030_ref21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jamaneurol.2015.3135","article-title":"Combined plasma and cerebrospinal fluid signature for the prediction of midterm progression from mild cognitive impairment to Alzheimer disease","volume":"73","author":"Lehallier","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-181030_ref22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bpsc.2016.08.006","article-title":"Plasma cortisol, brain amyloid-\u03b2, and cognitive decline in preclinical Alzheimer\u2019s disease: A 6-year prospective cohort study","volume":"2","author":"Pietrzak","year":"2017","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.3233\/JAD-181030_ref23","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/jama.1994.03510370056032","article-title":"Influence of education and occupation on the incidence of Alzheimer\u2019s disease","volume":"271","author":"Stern","year":"1994","journal-title":"JAMA"},{"key":"10.3233\/JAD-181030_ref24","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3233\/JAD-2009-1117","article-title":"Education attenuates the effect of medial temporal lobe atrophy on cognitive function in Alzheimer\u2019s disease: The MIRAGE study","volume":"17","author":"Perneczky","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181030_ref25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0895-4356(94)90157-0","article-title":"Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly","volume":"47","author":"White","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.3233\/JAD-181030_ref26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1076\/jcen.25.5.614.14581","article-title":"Lifetime antecedents of cognitive reserve","volume":"25","author":"Richards","year":"2003","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.3233\/JAD-181030_ref27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1176\/ajp.154.2.165","article-title":"Association of premorbid intellectual function with cerebral metabolism in Alzheimer\u2019s disease: Implications for the cognitive reserve hypothesis","volume":"154","author":"Alexander","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-181030_ref28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jalz.2012.10.002","article-title":"Brain size and the compensation of Alzheimer\u2019s disease symptoms: A longitudinal cohort study","volume":"9","author":"Guo","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181030_ref29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/gps.1205","article-title":"Intracranial volume in mild cognitive impairment, Alzheimer\u2019s disease and vascular dementia: Evidence for brain reserve?","volume":"19","author":"Wolf","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-181030_ref30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1076\/jcen.25.5.671.14584","article-title":"Head circumference, education and risk of dementia: Findings from the Nun Study","volume":"25","author":"Mortimer","year":"2003","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.3233\/JAD-181030_ref31","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.neuropsychologia.2009.03.004","article-title":"Cognitive reserve","volume":"47","author":"Stern","year":"2009","journal-title":"Neuropsychologia"},{"key":"10.3233\/JAD-181030_ref32","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer\u2019s disease","volume":"11","author":"Stern","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-181030_ref33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/WAD.0b013e3182900b2b","article-title":"Effect of cognitive reserve markers on Alzheimer pathologic progression","volume":"27","author":"Lo","year":"2013","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-181030_ref34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.nic.2005.09.008","article-title":"The Alzheimer\u2019s disease neuroimaging initiative","volume":"15","author":"Mueller","year":"2005","journal-title":"Neuroimaging Clin N Am"},{"key":"10.3233\/JAD-181030_ref35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jalz.2010.03.007","article-title":"The Alzheimer\u2019s disease neuroimaging initiative: Progress report and future plans","volume":"6","author":"Weiner","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181030_ref36","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.neurobiolaging.2013.05.015","article-title":"Estimated maximal and current brain volume predict cognitive ability in old age","volume":"34","author":"Royle","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-181030_ref37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): Clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-181030_ref38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-181030_ref39","first-page":"2","article-title":"Understanding and using factor scores: Considerations for the applied researcher","volume":"14","author":"DiStefano","year":"2009","journal-title":"Pract Assess Res Eval"},{"key":"10.3233\/JAD-181030_ref40","doi-asserted-by":"crossref","first-page":"428132","DOI":"10.4061\/2011\/428132","article-title":"Estimating premorbid intelligence among older adults: The utility of the AMNART","volume":"2011","author":"Lowe","year":"2011","journal-title":"J Aging Res"},{"key":"10.3233\/JAD-181030_ref41","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/01.WNL.0000103169.80910.8B","article-title":"Pronunciation of irregular words is preserved in dementia, validating premorbid IQ estimation","volume":"62","author":"McGurn","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-181030_ref42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/pubmed\/22.2.182","article-title":"The new UK National Statistics Socio-Economic Classification (NS-SEC); investigating social class differences in self-reported health status","volume":"22","author":"Chandola","year":"2000","journal-title":"J Public Health Med"},{"key":"10.3233\/JAD-181030_ref43","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/0962280210395740","article-title":"Review of inverse probability weighting for dealing with missing data","volume":"22","author":"Seaman","year":"2013","journal-title":"Stat Methods Med Res"},{"key":"10.3233\/JAD-181030_ref44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.dadm.2015.09.003","article-title":"Cerebrospinal fluid biomarkers in Alzheimer\u2019s disease: Diagnostic accuracy and prediction of dementia","volume":"1","author":"Forlenza","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-181030_ref45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","article-title":"Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: Differences between early- and late-onset Alzheimer disease and stability during the course of disease","volume":"56","author":"Andreasen","year":"1999","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-181030_ref46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jalz.2014.02.004","article-title":"Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer\u2019s disease","volume":"11","author":"Blennow","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181030_ref47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cca.2013.04.013","article-title":"High cortisol levels are associated with cognitive impairment no-dementia (CIND) and dementia","volume":"423","author":"Lara","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.3233\/JAD-181030_ref48","first-page":"269","article-title":"Brain corticosteroid receptor balance in health and disease","volume":"19","author":"De Kloet","year":"1998","journal-title":"Endocr Rev"},{"key":"10.3233\/JAD-181030_ref49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1998.tb09546.x","article-title":"Stress, adaptation, and disease. Allostasis and allostatic load","volume":"840","author":"McEwen","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-181030_ref50","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn2914","article-title":"The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration","volume":"11","author":"Lightman","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-181030_ref51","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2796.2000.00603.x","article-title":"The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke","volume":"247","author":"Rosmond","year":"2000","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-181030_ref52","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1172\/JCI119807","article-title":"Neural-immune interactions in health and disease","volume":"100","author":"Sternberg","year":"1997","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-181030_ref53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: A preliminary report","volume":"17","author":"Yesavage","year":"1982","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-181030_ref54","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/hup.266","article-title":"Stress and hippocampal plasticity: Implications for the pathophysiology of affective disorders","volume":"16","author":"McEwen","year":"2001","journal-title":"Hum Psychopharmacol"},{"key":"10.3233\/JAD-181030_ref55","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1210\/endo-117-6-2505","article-title":"Two receptor systems for corticosterone in rat brain: Microdistribution and differential occuation","volume":"117","author":"Reul","year":"1985","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-181030_ref56","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bph.13699","article-title":"Selection and early clinical evaluation of the brain-penetrant 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitor UE2343 (Xanamem)","volume":"174","author":"Webster","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JAD-181030_ref57","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"key":"10.3233\/JAD-181030_ref58","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF03345606","article-title":"Exercise and circulating cortisol levels: The intensity threshold effect","volume":"31","author":"Hill","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.3233\/JAD-181030_ref59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000103277","article-title":"Hormonal responses to a fast-food meal compared with nutritionally comparable meals of different composition","volume":"51","author":"Bray","year":"2007","journal-title":"Ann Nutr Metab"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-181030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:10:03Z","timestamp":1777371003000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-181030"}},"subtitle":[],"editor":[{"given":"Julius","family":"Popp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":59,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-181030","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,23]]}}}